Accumulating evidence suggests that intestinal bacteria promote enteric virus infection 25 in mice. For example, previous work demonstrated that antibiotic treatment of mice prior 26 to oral infection with poliovirus reduced viral replication and pathogenesis. Here we 27 examined the effect of antibiotic treatment on infection with coxsackievirus B3 (CVB3), a 28 picornavirus closely related to poliovirus. We treated mice with a mixture of five 29 antibiotics to deplete host microbiota and examined CVB3 replication and pathogenesis 30 following oral inoculation. We found that, like poliovirus, CVB3 shedding and 31 pathogenesis were reduced in antibiotic-treated mice. While treatment with just two 32 antibiotics, vancomycin and ampicillin, was sufficient to reduce CVB3 replication and 33 pathogenesis, this treatment had no effect on poliovirus. Quantity and composition of 34 bacterial communities were altered by treatment with the five antibiotic cocktail and by 35 treatment with vancomycin and ampicillin. To determine whether more subtle changes 36 in bacterial populations impact viral replication, we examined viral infection in mice 37 treated with milder antibiotic regimens. Mice treated with one-tenth the concentration of 38 the normal antibiotic cocktail supported replication of poliovirus but not CVB3.
Introduction
Microbiota composition of mice treated with different antibiotic regimens. To the five antibiotic cocktail reduced Eubacteria 16S rRNA gene copies over 80,000-fold 163 and treatment with ampicillin and vancomycin reduced Eubacteria 16S rRNA gene 164 copies by over 1,200-fold, and trends were similar for Bacteroidetes and Firmicutes 165 ( Fig. 4A-C) . As expected, the five antibiotic cocktail depleted bacteria more than the 166 ampicillin and vancomycin combination. To identify the microbial communities in each 167 treatment group, we performed 16S rRNA sequencing. We found that the overall 168 diversity of bacteria decreased in both mice treated with the five antibiotic cocktail and 169 mice treated with ampicillin plus vancomycin ( Fig. 4D ). While microbial communities 170 differed in mice treated with the five antibiotic cocktail vs. ampicillin and vancomycin 171 ( Fig. 4E ), the relative prevalence of distinct members of the microbiota were more 172 similar in the two antibiotic treatment groups than untreated controls ( Fig. 4F ). For 173 example, in untreated mice, Bacteroidetes and Firmicutes were the most prevalent, 174 while in the two different antibiotic treatment groups Tenericutes predominated. Overall, 175 these data suggest that both antibiotic treatment regimens alter host microbiota, but that 176 treatment with the cocktail of antibiotics depletes microbiota to a greater extent than 177 treatment with ampicillin and vancomycin. 178 179 CVB3, but not poliovirus, is sensitive to relatively minor perturbations of the 180 microbiota. Given that treatment with just ampicillin and vancomycin was sufficient to 181 inhibit CVB3 infection, we hypothesized that microbiota enhancement of CVB3 infection 182 may require relatively high numbers of bacteria. To test this, we treated mice with milder 183 antibiotic regimens. First, we treated mice with one-tenth of the normal dose (0.1X) of 184 9 the five antibiotic cocktail and then orally infected them with either 5x10 7 PFU of CVB3 185 or 2x10 7 PFU of poliovirus. Feces were harvested at 72 hours post-inoculation and 186 quantified via plaque assay. We found that treatment with the 0.1X five antibiotic 187 cocktail was sufficient to significantly reduce CVB3 shedding, while having no effect on 188 poliovirus shedding ( Fig. 5A ). To further examine the relative dependence of CVB3 and 189 poliovirus on microbiota, we treated mice with a single dose of one antibiotic, 190 streptomycin, the day prior to oral inoculation with 5x10 7 PFU of CVB3 or 2x10 7 PFU of 191 poliovirus. Feces were harvested at 72 hours post-inoculation and viral titers were 192 quantified via plaque assay. We found that mice treated with one dose of streptomycin 193 had significantly reduced CVB3 shedding, while poliovirus shedding was unaffected 194 ( Fig. 5B ). Furthermore, a single dose of streptomycin was sufficient to completely 195 rescue mice from CVB3-associated lethality ( Fig. 5C ), while there was no effect on 196 poliovirus-associated lethality (Fig. 5D ). These data suggest that CVB3 is more 197 sensitive to perturbations in the microbiota and that a single dose of one antibiotic can 198 dramatically alter the outcome of infection. Overall, our data suggest that these two 199 closely related enteric viruses have different microbiota requirements and mechanisms 200 of microbiota utilization.
In conclusion, we found that similar to poliovirus and other recently identified 244 enteric viruses, bacteria enhance CVB3 replication and viral-associated lethality.
245
Interestingly, a single dose of a clinically relevant broad-spectrum antibiotic, 246 streptomycin, was sufficient to reduce CVB3 replication and completely abolish CVB3-247 associated lethality, while having no effect on poliovirus. This result could have 248 implications for how standard antibiotic treatment regimens for bacterial infections could were prepared as previously described (20). CVB3 titers were determined by plaque 261 assay with HeLa cells (20, 21).
262
To determine whether fecal viruses were input/inoculum virus or virus that had 263 undergone replication, we used neutral-red-labeled, light-sensitive poliovirus as 264 described previously (24). Light inactivation was performed by exposing neutral red-265 poliovirus stocks to a fluorescent light bulb for 10 minutes. The ratio of light-insensitive 266 to light-sensitive PFU in the virus stock was 1 : 1.5x10 5 PFU. Following oral inoculation, 267 to determine the percentage of replicated virus in the intestine, samples were processed 268 in the dark and a portion was light exposed. The percentage of replicated virus was 269 calculated by dividing the light-exposed number of PFU/ml by the non-light-exposed 270 number of PFU/ml and multiplying by 100. experiments, feces were collected at indicated time points post-inoculation and 291 processed as previously described (9). Tissues were aseptically removed from mice 292 and homogenized in PBS using 0.9-to 2.0-mm stainless steel beads in a Bullet Blender 293 (Next Advance) and freeze-thawed 3 times in liquid nitrogen to release intracellular 294 virus. Cellular debris was removed by centrifugation at 13,000 RPM for 3 minutes. The 
Figure 1. Treatment with a cocktail of five antibiotics reduces CVB3 shedding and lethality.
Male C57BL/6 PVR +/+ IFNAR -/-mice were treated with or without a combination of 5 antibiotics (ampicillin, neomycin, streptomycin, metronidazole, and vancomycin) for 5 days by oral gavage followed by ad libitum administration in drinking water for 9 days prior to oral inoculation with 5x10 7 PFU of CVB3. Viral titers in feces collected at 24, 48, and 72 hours post-inoculation (A) or tissues collected at 72 hours post-inoculation (B) were determined by plaque assay. Data are mean ± SEM. *p<0.05, **p<0.001,***p<0.0001 Mann-Whitney Test. (C) Survival of untreated or antibiotic-treated mice orally inoculated with CVB3. *p<0.05, Log-rank test. n=9-25 mice per group.
B.
A. Male C57BL/6 PVR +/+ IFNAR -/-mice were treated with or without various antibiotics for 5 days by oral gavage followed by ad libitum administration in drinking water for 9 days prior to oral inoculation with 2x10 7 PFU of poliovirus. (A) Viral fecal titers at 24, 48, and 72 hours post inoculation were determined by plaque assay. (B) Viral replication efficiency was examined using light sensitive viruses. Mice were orally inoculated with neutral red-containing, light sensitive, poliovirus in the dark and feces were collected at 24, 48, and 72 hours post inoculation in the dark. Replication status was determined by dividing the number of PFU/ml of light-exposed samples (representing replicated virus) by the number of PFU/ml of dark-exposed samples (representing input/non-replicated virus plus replicated virus) and multiplying by 100%. Data are mean ± SEM. (C) Survival of untreated or ampicillin and vancomycin-treated mice following inoculation with 2x10 7 PFU of poliovirus. Log-rank test. n=11-12 mice per group. 
Figure 2

Figure 5 D.
A. B. Figure 5 . CVB3 replication is more sensitive to antibiotic treatment than poliovirus. (A) Male C57BL/6 PVR +/+ mice were treated with or without a combination of 5 antibiotics (ampicillin, neomycin, streptomycin, metronidazole, and vancomycin) at 0.1X concentration (one-tenth the standard concentration) for 5 days by oral gavage followed by 0.1X concentration ad libitum administration in drinking water for 9 days prior to oral inoculation with either 5x10 7 PFU of CVB3 or 2x10 7 of poliovirus. (A) Fecal titers at 72 hours post-inoculation were determined by plaque assay. (B-D) Male C57BL/6 PVR +/+ IFNAR -/-mice were treated with or without a single gavage of streptomycin the day prior to oral inoculation with either 5x10 7 PFU CVB3 or 2x10 7 PFU poliovirus. (B) CVB3 and poliovirus fecal titers at 72 hours post inoculation were determined by plaque assay. Survival of untreated or streptomycin treated mice orally inoculated with CVB3 (C) or poliovirus (D). Data are mean ± SEM. *p<0.05 Mann-Whitney Test. *p<0.05, Log-rank test. n=6-9 mice per group.
